BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1585 related articles for article (PubMed ID: 27340545)

  • 1. Progressive impairment of CaV1.1 function in the skeletal muscle of mice expressing a mutant type 1 Cu/Zn superoxide dismutase (G93A) linked to amyotrophic lateral sclerosis.
    Beqollari D; Romberg CF; Dobrowolny G; Martini M; Voss AA; Musarò A; Bannister RA
    Skelet Muscle; 2016; 6():24. PubMed ID: 27340545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of Abeta is associated with acceleration of onset of motor impairment and superoxide dismutase 1 aggregation in an amyotrophic lateral sclerosis mouse model.
    Li QX; Mok SS; Laughton KM; McLean CA; Volitakis I; Cherny RA; Cheung NS; White AR; Masters CL
    Aging Cell; 2006 Apr; 5(2):153-65. PubMed ID: 16626394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of peripheral nerve injury on disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Sharp PS; Dick JR; Greensmith L
    Neuroscience; 2005; 130(4):897-910. PubMed ID: 15652988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intact single muscle fibres from SOD1
    Cheng AJ; Allodi I; Chaillou T; Schlittler M; Ivarsson N; Lanner JT; Thams S; Hedlund E; Andersson DC
    J Physiol; 2019 Jun; 597(12):3133-3146. PubMed ID: 31074054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perturbations in intracellular Ca2+ handling in skeletal muscle in the G93A*SOD1 mouse model of amyotrophic lateral sclerosis.
    Chin ER; Chen D; Bobyk KD; Mázala DA
    Am J Physiol Cell Physiol; 2014 Dec; 307(11):C1031-8. PubMed ID: 25252949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective mitochondrial dynamics is an early event in skeletal muscle of an amyotrophic lateral sclerosis mouse model.
    Luo G; Yi J; Ma C; Xiao Y; Yi F; Yu T; Zhou J
    PLoS One; 2013; 8(12):e82112. PubMed ID: 24324755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
    Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
    Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
    Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional over-load saves motor units in the SOD1-G93A transgenic mouse model of amyotrophic lateral sclerosis.
    Gordon T; Tyreman N; Li S; Putman CT; Hegedus J
    Neurobiol Dis; 2010 Feb; 37(2):412-22. PubMed ID: 19879358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid precursor protein (APP) contributes to pathology in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Bryson JB; Hobbs C; Parsons MJ; Bosch KD; Pandraud A; Walsh FS; Doherty P; Greensmith L
    Hum Mol Genet; 2012 Sep; 21(17):3871-82. PubMed ID: 22678056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different human copper-zinc superoxide dismutase mutants, SOD1G93A and SOD1H46R, exert distinct harmful effects on gross phenotype in mice.
    Pan L; Yoshii Y; Otomo A; Ogawa H; Iwasaki Y; Shang HF; Hadano S
    PLoS One; 2012; 7(3):e33409. PubMed ID: 22438926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of metal concentrations in the SOD1
    Enge TG; Ecroyd H; Jolley DF; Yerbury JJ; Kalmar B; Dosseto A
    Mol Cell Neurosci; 2018 Apr; 88():319-329. PubMed ID: 29524628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
    Van Dyke JM; Smit-Oistad IM; Macrander C; Krakora D; Meyer MG; Suzuki M
    Exp Neurol; 2016 Mar; 277():275-282. PubMed ID: 26775178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time course of preferential motor unit loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
    Hegedus J; Putman CT; Gordon T
    Neurobiol Dis; 2007 Nov; 28(2):154-64. PubMed ID: 17766128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycoprotein nonmetastatic melanoma protein B ameliorates skeletal muscle lesions in a SOD1G93A mouse model of amyotrophic lateral sclerosis.
    Nagahara Y; Shimazawa M; Tanaka H; Ono Y; Noda Y; Ohuchi K; Tsuruma K; Katsuno M; Sobue G; Hara H
    J Neurosci Res; 2015 Oct; 93(10):1552-66. PubMed ID: 26140698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trehalose decreases mutant SOD1 expression and alleviates motor deficiency in early but not end-stage amyotrophic lateral sclerosis in a SOD1-G93A mouse model.
    Li Y; Guo Y; Wang X; Yu X; Duan W; Hong K; Wang J; Han H; Li C
    Neuroscience; 2015 Jul; 298():12-25. PubMed ID: 25841320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early changes of neuromuscular transmission in the SOD1(G93A) mice model of ALS start long before motor symptoms onset.
    Rocha MC; Pousinha PA; Correia AM; Sebastião AM; Ribeiro JA
    PLoS One; 2013; 8(9):e73846. PubMed ID: 24040091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stabilization of mutant Cu/Zn superoxide dismutase (SOD1) protein by coexpressed wild SOD1 protein accelerates the disease progression in familial amyotrophic lateral sclerosis mice.
    Fukada K; Nagano S; Satoh M; Tohyama C; Nakanishi T; Shimizu A; Yanagihara T; Sakoda S
    Eur J Neurosci; 2001 Dec; 14(12):2032-6. PubMed ID: 11860498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel behavioural characteristics of the superoxide dismutase 1 G93A (SOD1
    Kreilaus F; Guerra S; Masanetz R; Menne V; Yerbury J; Karl T
    Genes Brain Behav; 2020 Feb; 19(2):e12604. PubMed ID: 31412164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Equivalent L-type channel (Ca
    Beqollari D; Kohrt WM; Bannister RA
    Biochem Biophys Res Commun; 2020 Feb; 522(4):996-1002. PubMed ID: 31812241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 80.